Entero Healthcare Solutions Latest Share Price (ENTERO)
TODAY IN ONE LINE
ENTERO slipped 0.5% on light volume, in line with Nifty's -0.1% move, supported by recent strong earnings.
With a market cap of ₹6,147.63 Cr., it trades at a P/E of 49.29. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Entero Healthcare Solutions flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●High Promoter HoldingPromoters hold 52.4% skin-in-the-game
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Capital ReturnsLow ROE of 7.0%
- ●FII SellingFII holding decreased by 2.53% QoQ
- ●Rising Receivables vs SalesReceivables grew 35.5% outpacing sales growth of 29.9%
Latest Entero Healthcare Solutions News
What changed recently?
Recent events, corporate actions, and announcements.
Entero Healthcare Solutions Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Entero Healthcare Solutions Limited, framed against the sector median so the premium or discount is obvious at a glance.
Entero Healthcare Solutions Limited trades at a P/E of 49.29× and P/B of 3.66×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Entero Healthcare Solutions Limited technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for Entero Healthcare Solutions Limited — derived from the latest tape, not yesterday's close.
Entero Healthcare Solutions Limited last traded at ₹1,409.1 with an intraday range of ₹1,406.5–₹1,448 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹1409.10| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1518.90 | +109.80 | +7.79% |
| R3 | 1477.40 | +68.30 | +4.85% |
| R2 | 1462.70 | +53.60 | +3.80% |
| R1 | 1435.90 | +26.80 | +1.90% |
| PIVOT | 1421.20 | 12.10 | 0.86% |
| CURRENT | 1409.10 | — | — |
| S1 | 1394.40 | -14.70 | -1.04% |
| S2 | 1379.70 | -29.40 | -2.09% |
| S3 | 1352.90 | -56.20 | -3.99% |
| S4 | 1311.40 | -97.70 | -6.93% |
ENTERO is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹1410–₹1448
Trading Below opening range, showing Bearishness
Entero Healthcare Solutions Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Entero Healthcare Solutions Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
Entero Healthcare Solutions Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹6,147.63 Cr. and reported EPS of ₹28.76.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 5,096 | 6,591 ▲ 29.3% |
| Sales Growth YoY %Derived | 29.92% | 29.35% |
| Other Income | 40 | 19 ▼ 51.3% |
| Total Income | 5,135 | 6,610 ▲ 28.7% |
| 4,609 | 5,911 ▲ 28.2% | |
| Gross ProfitDerived | 486 | 680 ▲ 39.9% |
| Gross Margin %Derived | 9.54% | 10.32% |
| 315 | 414 ▲ 31.7% | |
| EBITDA (Operating Profit)Derived | 172 | 266 ▲ 55.0% |
| OPM %Derived | 3.37% | 4.03% |
| 72 | 90 ▲ 23.8% | |
| Profit Before Tax (PBT) | 139 | 179 ▲ 29.3% |
| 31 | 33 ▲ 7.0% | |
| Effective Tax %Derived | 22.56% | 18.68% |
| Total Profit for Period | 107 | 146 ▲ 35.7% |
| Less: Non-controlling Interests | 13 | 31 ▲ 144.2% |
| Net Profit (Owner's PAT)Derived | 95 | 115 ▲ 21.3% |
| Net Profit Margin %Derived | 1.86% | 1.75% |
| PAT Growth YoY %Derived | 142.45% | 21.33% |
| Earnings Per Share (EPS ₹) | 21.79 | 26.44 ▲ 21.3% |
| Diluted Shares Outstanding (Cr) | 4 | 4 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | 0 | -1 ▼ 221.4% |
| Total Expenses (incl. D&A & Interest) | 4,997 | 6,431 ▲ 28.7% |
| Material Cost % of RevenueDerived | — | — |
| Employee Cost % of RevenueDerived | 3.91% | 3.72% |
| Other Cost % of RevenueDerived | 2.27% | 2.56% |
| Interest Coverage (x)Derived | 3.38x | 4.09x |
| Period | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|
| Revenue from Operations | 3,922 | 5,096 ▲ 29.9% | 6,591 ▲ 29.3% | |
| Sales Growth YoY %Derived | — | 29.92% | 29.35% | |
| Other Income | 14 | 40 ▲ 174.1% | 19 ▼ 51.3% | |
| Total Income | 3,937 | 5,135 ▲ 30.4% | 6,610 ▲ 28.7% | |
3,570 | 4,609 ▲ 29.1% | 5,911 ▲ 28.2% | ||
| Gross ProfitDerived | 352 | 486 ▲ 38.2% | 680 ▲ 39.9% | |
| Gross Margin %Derived | 8.97% | 9.54% | 10.32% | |
240 | 315 ▲ 31.1% | 414 ▲ 31.7% | ||
| EBITDA (Operating Profit)Derived | 112 | 172 ▲ 53.4% | 266 ▲ 55.0% | |
| OPM %Derived | 2.85% | 3.37% | 4.03% | |
91 | 72 ▼ 20.3% | 90 ▲ 23.8% | ||
| Profit Before Tax (PBT) | 36 | 139 ▲ 290.2% | 179 ▲ 29.3% | |
-4 | 31 ▲ 837.6% | 33 ▲ 7.0% | ||
| Effective Tax %Derived | -11.94% | 22.56% | 18.68% | |
| Total Profit for Period | 40 | 107 ▲ 169.9% | 146 ▲ 35.7% | |
| Less: Non-controlling Interests | 1 | 13 ▲ 1727.6% | 31 ▲ 144.2% | |
| Net Profit (Owner's PAT)Derived | 39 | 95 ▲ 142.5% | 115 ▲ 21.3% | |
| Net Profit Margin %Derived | 1.00% | 1.86% | 1.75% | |
| PAT Growth YoY %Derived | — | 142.45% | 21.33% | |
| Earnings Per Share (EPS ₹) | 8.99 | 21.79 ▲ 142.4% | 26.44 ▲ 21.3% | |
| Diluted Shares Outstanding (Cr) | 4 | 4 ▲ 0.0% | 4 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | -0 | 0 ▲ 324.7% | -1 ▼ 221.4% | |
| Total Expenses (incl. D&A & Interest) | 3,901 | 4,997 ▲ 28.1% | 6,431 ▲ 28.7% | |
| Material Cost % of RevenueDerived | — | — | — | |
| Employee Cost % of RevenueDerived | 3.85% | 3.91% | 3.72% | |
| Other Cost % of RevenueDerived | 2.27% | 2.27% | 2.56% | |
| Interest Coverage (x)Derived | 1.32x | 3.38x | 4.09x |
Entero Healthcare Solutions segment analysis : revenue and profit mix.
Disclosed business segments at Entero Healthcare Solutions with their share of revenue and profit, switchable between consolidated and standalone reporting.
Entero Healthcare Solutions discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Entero Healthcare Solutions Limited.
Our AI distills the core fundamental drivers supporting Entero Healthcare Solutions Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Entero Healthcare Solutions Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
TTM revenue surged 42.6% YoY, demonstrating robust market demand and strong growth trajectory.
Latest quarterly EPS grew 9.0% YoY with sales up 42.60% YoY, showing operational leverage.
Promoter holding stable at 52.42%, reflecting confident long-term commitment and alignment.
Low debt-to-equity ratio of 0.0040 provides substantial financial flexibility for investments.
Cash flow per share ₹22.10 annually indicates solid liquidity and operational cash generation.
Key Risks.
Operating margin 3.38% TTM remains thin, limiting profitability and reinvestment capacity.
Net profit margin 1.75% TTM is compressed, indicating cost pressures in distribution model.
Operating cash flow negative ₹59.72 Cr in FY2026, signaling working capital strain and cash burn.
ROE 6.99% and ROCE 10.60% lag peer benchmarks, suggesting suboptimal capital efficiency.
Zero dividend yield provides no income component, limiting appeal to yield-seeking investors.
Flip Conditions.
Valuation risk. a P/E above 64 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Entero Healthcare Solutions Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Entero Healthcare Solutions Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Entero Healthcare Solutions Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Entero Healthcare Solutions Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Entero Healthcare Solutions Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Entero Healthcare Solutions Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Entero Healthcare Solutions Limited stood at 46.6% of traded volume, against a 20-day average of 49.9%.
Entero Healthcare Solutions announcements: results, concalls, ratings, M&A.
Filings Entero Healthcare Solutions sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Entero Healthcare Solutions files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 142 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
Entero Healthcare Solutions Limited has informed the Exchange about Link of Recording on Unaudited Financial Results of the Company for the quarter…
Copy of Newspaper Publication
Entero Healthcare Solutions Limited has informed the Exchange about Copy of Newspaper Publication for Unaudited Financial Results for the quarter…
Investor Presentation
Entero Healthcare Solutions Limited has informed the Exchange about Investor Presentation
Outcome of Board Meeting
Entero Healthcare Solutions Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
General Updates
Entero Healthcare Solutions Limited has informed the Exchange about Revised intimation of the Earnings Call on the Unaudited Financial Results of the…
Investor decks & rating reports.
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Entero Healthcare Solutions dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Entero Healthcare Solutions has declared, sequenced by announce and record date.
Entero Healthcare Solutions corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Entero Healthcare Solutions Limited: business, sector, key facts.
What Entero Healthcare Solutions Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Entero Healthcare Solutions Limited operates in the Pharmacy Retail industry under the Consumer Services sector, listed as NSE: ENTERO, BSE: 544122.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited is a Mumbai-based Indian company established in 2018 that operates within the healthcare sector. Its core business revolves around the distribution and trading of a wide range of pharmaceutical and surgical products. This extensive portfolio caters to a diverse clientele, including retail pharmacies, hospitals, manufacturers of healthcare products, and healthcare clinics across India.
The company's distribution network encompasses several key product categories. A significant portion of its business involves medical devices, a market segment experiencing considerable growth in India. This includes a variety of products designed for both professional and home healthcare settings. Entero also distributes over-the-counter (OTC) medical products, offering readily accessible healthcare solutions to consumers.
Further diversifying its offerings, Entero distributes nutraceuticals, which are products intended to supplement dietary intake and improve overall health and well-being. This area taps into the rising consumer awareness and demand for health-conscious choices. The company also plays a role in the distribution of vaccines, contributing to crucial public health initiatives and disease prevention programs within the country.
In addition to its broader distribution activities, Entero offers specific medical devices directly to consumers. Examples of these products include nebulizers for respiratory treatments, digital thermometers for accurate temperature readings, blood pressure monitors for cardiovascular health monitoring, and adult diapers for incontinence care. This direct-to-consumer approach complements its wholesale distribution operations and solidifies its position in the healthcare market.
In summary, Entero Healthcare Solutions Limited's business model combines wholesale distribution to healthcare institutions and direct-to-consumer sales of select medical devices. Its diverse product portfolio, spanning pharmaceuticals, surgical supplies, medical devices, nutraceuticals, and vaccines, positions it as a significant player in the dynamic Indian healthcare market. The company’s relatively recent founding suggests a growth trajectory focused on expanding its market reach and product offerings within the Indian healthcare landscape.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Aditya Birla Lifestyle Brands (ABLBL) Share PricePeer
- Advent Hotels International (ADVENTHTL) Share PricePeer
- Asian Hotels (West) (AHLWEST) Share PricePeer
- Apollo Sindoori Hotels (APOLSINHOT) Share PricePeer
- Blue Coast Hotels (BLUECOAST) Share PricePeer
- Stocks near 52-week high (breakout watch)Screener
- Breakout Trader strategy playbookStrategy
- Other overvalued NSE stocksScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Entero Healthcare Solutions Limited (ENTERO).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Entero Healthcare Solutions Limited (ENTERO)?
The current share price of Entero Healthcare Solutions Limited (ENTERO) is ₹1,409.10. Today, the stock has declined by ₹7.50 (0.53%), trading in a range of ₹1,406.50 to ₹1,448.00. The stock opened at ₹1,448.00 with a trading volume of 35,875 shares.
02Is Entero Healthcare Solutions Limited stock a good investment for long-term?
Entero Healthcare Solutions Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹6,147.63 Cr., P/E ratio of 49.29, ROE of 6.99%, and ROCE of 10.6%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Entero Healthcare Solutions Limited stock?
The 52-week high price of Entero Healthcare Solutions Limited (ENTERO) is ₹1,467.80, while the 52-week low is ₹944.00. Currently trading at ₹1,409.10, the stock is 49.27% above its 52-week low and 4% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Entero Healthcare Solutions Limited stock at the current price?
Whether to buy Entero Healthcare Solutions Limited stock at ₹1,409.10 depends on multiple factors. The stock is currently trading with a P/E ratio of 49.29 and P/B ratio of 3.66. Today's performance shows a loss of 0.53%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Entero Healthcare Solutions Limited and when is the next dividend?
Entero Healthcare Solutions Limited offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹1,409.10, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Entero Healthcare Solutions Limited?
Entero Healthcare Solutions Limited's key financial metrics include: P/E Ratio: 49.29, P/B Ratio: 3.66, ROE: 6.99%, ROCE: 10.6%, Dividend Yield: 0%, EPS: ₹28.76, Book Value: ₹388.09, and Debt-to-Equity: 0.4. The company's market cap stands at ₹6,147.63 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Entero Healthcare Solutions Limited stock performing today in the market?
Entero Healthcare Solutions Limited stock opened at ₹1,448.00 and is currently trading at ₹1,409.10, showing a decline of ₹7.50 (0.53%). The intraday high is ₹1,448.00 and low is ₹1,406.50. The trading volume stands at 35,875 shares, indicating moderate market participation today.
08What is the P/E ratio of Entero Healthcare Solutions Limited and what does it indicate?
Entero Healthcare Solutions Limited has a Price-to-Earnings (P/E) ratio of 49.29, which means investors are willing to pay 49.29 for every ₹1 of earnings. With an EPS of ₹28.76, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Entero Healthcare Solutions Limited (ENTERO) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.